---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-262188"
form_type: "8-K"
ticker: "DNTH"
cik: "0001690585"
company_name: "Dianthus Therapeutics, Inc. /DE/"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:54:23.652849+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Dianthus Therapeutics posts updated corporate presentation; no specific material changes disclosed

## Summary
- Updated corporate presentation posted on company's investor relations website on November 3, 2025.
- Presentation filed as Exhibit 99.1 to the 8-K; detailed content not available in the excerpt provided.
- No financial results, pipeline updates, or guidance changes are included in the filing text.
- Routine update; no material new operational or strategic information identified.

## SEC filing metadata
- accession: 0001193125-25-262188
- form_type: 8-K
- ticker: DNTH
- cik: 0001690585
- company_name: Dianthus Therapeutics, Inc. /DE/
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690585/000119312525262188/0001193125-25-262188-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690585/000119312525262188/dnth-20251103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-262188
- JSON: https://secwatch.observer/filing/0001193125-25-262188.json
- Plain text: https://secwatch.observer/filing/0001193125-25-262188.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.